AN2 Therapeutics, Inc. (ANTX) stock
ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.55+0.11 (+2.48%)
Close on Nov 13, 2026Market cap $171.70MP/E –Yield –
AN2 Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AN2 Therapeutics's enterprise value was $83.55M on Nov 11, 2026, against -$32.09M a year earlier. Over the last 5 years it ranged from -$72.62M to $485.58M, with a median of $26.62M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $83.55M | – |
| 2025 | Dec 31, 2025 | -$30.72M | – |
| 2024 | Dec 31, 2024 | -$52.21M | -110.8% |
| 2023 | Dec 29, 2023 | $485.58M | +503.2% |
| 2022 | Dec 30, 2022 | $80.51M | – |
See a number that looks wrong?